Navigation Links
Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
Date:9/10/2008

SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Bank of America 38th Annual Investment Conference on Tuesday, September 16, 2008 at approximately 8 a.m. Pacific Time. The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at http://www.gen-probe.com. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risk
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
2. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
5. Carl Hull Named President and Chief Operating Officer of Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
7. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
8. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
9. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
10. Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
11. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Dec. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: ... and medical device research and,development outsourcing company ... States,announced today it has purchased a Labcyte ... 555 acoustic liquid handler for its work ... WuXi PharmaTech joins the,growing number of pharmaceutical ...
(Date:12/4/2009)... Products (ACAMP) hosts, health & ... Today ACAMP hosted a health & medical seminar, ... can play a powerful role in the creation ... and improve the quality, cost and outcomes of ...
(Date:12/3/2009)... INC. (OTC Bulletin Board: ACCP), ... of MuGard, an FDA approved treatment for oral mucositis, ... MuGard is commercially launched by Access, partner, SpePharm, in ... Greece and Sweden. Access is conducting pre-marketing activities, including ...
(Date:12/3/2009)... Sciences, Inc. (Nasdaq: CALP ), a leading provider ... sciences research, today introduced Living Image 4.0 software for ... the more than 800 Caliper IVIS systems currently installed ... unmixing tools to enhance fluorescent sensitivity and automated 3D ...
Breaking Biology Technology:WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2Alberta companies delivering new products to the health & medical marketplace 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2
... Dialysis and Earlier Stage ... Chronic Kidney Disease Patients, CAMBRIDGE, Mass., ... the U.S. launch of the phosphate binder,Renvela(R) (sevelamer carbonate) for ... to secure additional,approvals for the product., Genzyme has submitted ...
... grounding pads ... and accessories, MUNDELEIN, ... an exclusive license and supply agreement for 3M,s,electrosurgical patient plates in ... and sales rights in the United,States for 3M,s electrosurgical patient plates ...
... 6 PharmAthene, Inc., a,biodefense company specializing in ... and biological threats, announced,today that it has completed ... broad spectrum chemical nerve agent prophylaxis., The ... and used the final,pegylated version of rBChE for ...
Other Biology Technology:Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 2Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 3Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 4Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 5Medline and 3M Agree to Strategic Partnership in Electrosurgery 2Medline and 3M Agree to Strategic Partnership in Electrosurgery 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 4
(Date:12/2/2009)... head and neck cancer diagnosis strongly predicts the patient,s ... results of a new study show a similar effect ... , "Most cancer survivors are counseled to quit smoking; ... percent continued to smoke even after their cancer diagnosis, ...
(Date:12/2/2009)... PHILADELPHIA Mexican-American adolescents exposed to cigarette smoking ... up the habit themselves, and this may be ... initiation, according to new study findings. , "Our ... United States and highlights the global implementation of ...
(Date:12/2/2009)... PHILADELPHIA Assurance of a cancer-free status did ... tomography (CT) lung-cancer screening program to pick up ... published in Cancer Epidemiology, Biomarkers & Prevention ... Cancer Research. The December issue contains a special ...
Breaking Biology News(10 mins):Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UNC scientists garner new NIH awards for high risk transformative research 10076 1UNC scientists garner new NIH awards for high risk transformative research 10076 2UNC scientists garner new NIH awards for high risk transformative research 10076 3UNC scientists garner new NIH awards for high risk transformative research 10076 4Narconon Drug Rehab Educates Children Parents at County Fair 58218 1Narconon Drug Rehab Educates Children Parents at County Fair 58218 2OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 1OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 2
... When it comes to the deadly skin cancer ... may better provide insight into the disease's development, ... Medical Institute predoctoral fellow at Stanford University School ... associated with melanoma development, scientists have not been ...
... cancer melanoma, studying functional tissue rather than cell ... development, according to new research from a Howard ... School of Medicine. , Though multiple genetic alterations ... been able to establish a direct causal link ...
... the Spinal Injuries Research Centre at the Prince of ... the Christopher Reeve Paralysis Foundation to prepare a three-dimensional ... next two years. , Christopher Reeve met with Institute ... was impressed with their work in spinal injuries research. ...
Other Biology News:Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 2Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 3Engineered skin offers clues to melanoma development 2Engineered skin offers clues to melanoma development 33D Atlas Will Help Navigate The Spinal Cord 2
... polyclonal to HDAC4 - ChIP Grade ... II mammalian histone deacetylases, which consists of ... is highly similar to the deacetylase domain ... shuttles between the nucleus and cytoplasm in ...
Our Histology, Immunohistochemistry and tissue arrays services include samples processing, different type of staning, histollogical stains, image analysis, tissue arrays, immunohistochemistry, etc....
Mouse monoclonal antibody raised against a partial recombinant FBXO24. NCBI Entrez Gene ID = FBXO24...
...
Biology Products: